De Dora Capital, Inc. Viatris Inc Transaction History

De Dora Capital, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$9.95 - $12.27 $144,692 - $178,430	-14,542 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$9.81 - $15.4 $142,657 - $223,946	14,542 New	14,542 $158,000
Q4 2021 Jan 18, 2022	SELL	$12.09 - $14.68 $243,154 - $295,244	-20,112 Closed	0 $0
Q3 2021 Oct 18, 2021	SELL	$13.25 - $15.13 $11,779 - $13,450	-889 Reduced 4.23%	20,112 $273,000
Q2 2021 Aug 03, 2021	BUY	$12.97 - $16.15 $830 - $1,033	64 Added 0.31%	21,001 $300,000
Q1 2021 Apr 27, 2021	BUY	$13.59 - $18.54 $284,533 - $388,171	20,937 New	20,937 $292,000

1,095

930M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of De Dora Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on De Dora Capital, Inc. with notifications on news.